Finch Therapeutics Group Stock Price, News & Analysis

FNCH OTC Link

Company Description

Welcome to the overview page for Finch Therapeutics Group (FNCH), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-12.07%

Performance 1 year

$5.0M

Market Cap

1.6M

Shares outstanding

Latest News

View All

October 21, 2024

+1.90%

Finch Announces Delisting from Nasdaq and SEC Deregistration

June 9, 2023

-4.91%

Finch Announces Reverse Stock Split of Common Stock

stock split

May 10, 2023

-5.95%

Finch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates

earnings

April 25, 2023

+4.24%

Finch Therapeutics Announces Executive Leadership Transitions

management

April 18, 2023

-3.13%

Finch Therapeutics Announces Clinical Collaboration in Ulcerative Colitis with Brigham and Women’s Hospital and Updates to University of Minnesota License Agreement

March 23, 2023

-7.50%

Finch Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates

earnings

SEC Filings

View All

No SEC filings available for Finch Therapeutics Group.

Financial Highlights

View Full Financials

$107K

Revenue (TTM)

-$74.8M

Net Income (TTM)

$-46.59

Diluted EPS (TTM)

-$31.5M

Operating Cash Flow

-69863.6%

Net Profit Margin

-78374.8%

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Loading short interest data...

Short interest in Finch Therapeutics Group (FNCH) currently stands at 66 shares, up 73.7% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 96%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months

Loading days to cover data...

Days to cover for Finch Therapeutics Group (FNCH) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.

Frequently Asked Questions

What is the current stock price of Finch Therapeutics Group (FNCH)?

The current stock price of Finch Therapeutics Group (FNCH) is $13.3 as of February 13, 2026.

What is the market cap of Finch Therapeutics Group (FNCH)?

The market cap of Finch Therapeutics Group (FNCH) is approximately 5.0M. Learn more about what market capitalization means .

What is the revenue (TTM) of Finch Therapeutics Group (FNCH) stock?

The trailing twelve months (TTM) revenue of Finch Therapeutics Group (FNCH) is $107K.

What is the net income of Finch Therapeutics Group (FNCH)?

The trailing twelve months (TTM) net income of Finch Therapeutics Group (FNCH) is -$74.8M.

What is the earnings per share (EPS) of Finch Therapeutics Group (FNCH)?

The diluted earnings per share (EPS) of Finch Therapeutics Group (FNCH) is $-46.59 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Finch Therapeutics Group (FNCH)?

The operating cash flow of Finch Therapeutics Group (FNCH) is -$31.5M. Learn about cash flow.

What is the profit margin of Finch Therapeutics Group (FNCH)?

The net profit margin of Finch Therapeutics Group (FNCH) is -69863.6%. Learn about profit margins.

What is the operating margin of Finch Therapeutics Group (FNCH)?

The operating profit margin of Finch Therapeutics Group (FNCH) is -78374.8%. Learn about operating margins.

What is the current ratio of Finch Therapeutics Group (FNCH)?

The current ratio of Finch Therapeutics Group (FNCH) is 6.33, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of Finch Therapeutics Group (FNCH)?

The operating income of Finch Therapeutics Group (FNCH) is -$83.9M. Learn about operating income.